CoChat

Identification of metformin poor responders, requiring supplemental insulin, during randomization of metformin versus insulin for the control of gestational diabetes mellitus

Ashoush, Sherif, El‐Said, Mourrad, Fathi, Hisham, Abdelnaby, Mohamed · 2016 · Journal of Obstetrics and Gynaecology Research
Cited by 80

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aim: To evaluate glycemic control among women with gestational diabetes mellitus (GDM) under insulin versus metformin (with or without insulin supplementation), and to identify metformin poor responders requiring supplemental insulin. Methods: In Ain Shams University Hospital, mothers with 26–32‐week GDM pregnancies, failing diet control, were randomized to receive metformin (n = 47) or insulin (n = 48). The primary outcome was glycemic control. Secondary outcomes included maternal weight, parameters predicting successful metformin monotherapy, neonatal hypoglycemia, and birthweight. Results: Women using metformin (23.4% needing supplemental insulin) gained less weight (P < 0.001), and had lower fasting glucose during the first and last 2 weeks of treatment (P = 0.014 and 0.008, respectively) when compared with insulin monotherapy. Insulin supplementation in the metformin group was related to initial body mass index, HbA1c, oral glucose tolerance test (GTT), and first week mean glucose level. The 1‐h glucose level during initial GTT (Hr1‐GTT) and the mean fasting glucose level during the first week of therapy (Wk1‐mFG) were the two independent parameters associated with requiring supplemental insulin. Women with Hr1‐GTT >212 mg/dL and Wk1‐mFG >95 mg/dL had a risk ratio of 58.6 (95%CI: 3.68–933.35, P = 0.004) and 11.5 (95%CI: 2.77–47.34,= 0.0008), respectively for needing supplemental insulin during the course of the study compared with women without. Conclusion: Metformin is an effective and safe alternative to insulin in GDM. Women using metformin (± supplemental insulin) had similar glycemic control, less weight gain, and similar rates of side‐effects as those on insulin monotherapy. Insulin supplementation to metformin therapy was more likely with elevated Hr1‐GTT and Wk1‐mFG.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jog.12950

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 80

Metadata

Authors
Ashoush, S., El‐Said, M., Fathi, H., & Abdelnaby, M.
Venue
Journal of Obstetrics and Gynaecology Research
Publisher
Wiley
Published
2016-03-15
Volume
42
Issue
6
Pages
640-647
ISSN
  • 1341-8076 (ISSN-L)
  • 1447-0756
OpenAlex
W2297880637
Cited by
80
References
4
FWCI
6.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of metformin poor responders, requiring supplemental insulin, during randomization of metformin versus insulin for the control of gestational diabetes mellitus. https://app.cochat.ai/papers/10.1111/jog.12950
The paper
Ashoush, S., El‐Said, M., Fathi, H., & Abdelnaby, M. (2016). Identification of metformin poor responders, requiring supplemental insulin, during randomization of metformin versus insulin for the control of gestational diabetes mellitus. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.12950

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.